Purchase Order 75N93024P01094

Award Date 9/3/24
Potential Completion Date 11/30/24
Potential Value $57K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Pleasanton, CA 94588, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
2
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a firm fixed price purchase order awarded by the National Institute of Allergy and Infectious Diseases (NIAID), part of the U.S. Department of Health and Human Services, to 10X Genomics, Inc. for products and services to support COVID-19 research. The $95,000 contract provides Visium CytAssist for FFPE Spatial Gene Expression products, including dual index kits and reagent kits. It was awarded under a total small business set-aside through a simplified acquisition procedure. 10X Genomics...
This is a firm fixed price purchase order contract awarded by the National Institute of Allergy and Infectious Diseases, part of the Department of Health and Human Services' National Institutes of Health (NIH), to 10X Genomics, Inc. The contract, valued at $100,100.00, is for the provision of 10X Genomics' specialized genomics analysis products and services, including kits, instruments, and supporting services for single-cell and spatial analysis applications. The contract supports biomedical...
This firm fixed price purchase order was awarded by the National Institute of Allergy and Infectious Diseases (NIAID), part of the Department of Health and Human Services, to 10X Genomics, Inc. for the purchase of Chromium Next GEM kits and accessories totaling $77,932.32. The award was made under a competitive 8(a) small business set-aside solicitation for commercial laboratory instruments and supplies to support biomedical research. 10X Genomics, a life sciences technology company, will...
The National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency within the U.S. Department of Health and Human Services, awarded a firm fixed price purchase order worth $35,916.00 to 10X Genomics, Inc., a small business manufacturer of life sciences products and services. The award, which was set aside for small businesses, is for the supply of 10X Genomics' Visium HD, Mouse Transcriptome, 6.5 mm product under a brand name restriction. This procurement was conducted using...
The Department of Health and Human Services' National Institutes of Health (NIH) National Institute of Allergy and Infectious Diseases awarded a firm fixed price purchase order to 10X Genomics, Inc., a life sciences technology company, for $128,562.00. The order is for 10X Genomics' products and services, including 10X Genomics' Chromium Next GEM Single Cell 5' Kits, 5' Feature Barcode Kits, Chromium Next GEM Chip G Single Cell Kits, Chromium Single Cell Human BCR and TCR Amplification Kits, and...
This firm fixed-price Purchase Order contract was awarded by the National Institute of Allergy and Infectious Diseases (NIAID), part of the U.S. Department of Health and Human Services, to 10X Genomics, Inc., a life sciences technology company, for the supply of VISIUM CYTASSIST FOR FFPE SPATIAL GENE EXPRESSION KITS. The contract has a ceiling value of $11,049.00 and a period of performance ending on January 16, 2025. It was set aside for small businesses. 10X Genomics is the prime contractor...
The Department of Health and Human Services' National Institutes of Health (NIH) National Institute of Allergy and Infectious Diseases (NIAID) awarded a $178,891.74 firm fixed price purchase order to 10X Genomics, Inc. to provide Visium CytAssist Instruments and Visium Spatial Reagents. This contract is a small business set-aside and has a completion date of September 29, 2023. The products and services are to support biomedical research efforts, including optimization slides, reagent kits,...
This firm fixed-price purchase order was awarded to 10X Genomics, Inc., a life sciences technology company, by the National Institute on Aging, a part of the National Institutes of Health (NIH) within the U.S. Department of Health and Human Services. The $53,388 contract provides 10X Genomics' specialized genomic analysis products and services, including kits for single-cell RNA sequencing, single-cell ATAC sequencing, single-cell multi-omics, and spatial transcriptomics, as well as the...
This contract award to 10X Genomics, Inc. (10X Genomics) was made by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), a civilian agency within the U.S. Department of Health and Human Services. The $22,585.50 firm fixed-price purchase order is for 10X Genomics' 10X CHROMIUM NEXT GEM SINGLE CELL REAGENTS KIT, to be delivered by January 2, 2025. This order is not designated as a set-aside contract. 10X Genomics is a life sciences...
This $153,774.75 firm fixed price purchase order was awarded to 10X Genomics, Inc. by the Department of Health and Human Services' National Institutes of Health (NIH) National Institute of Allergy and Infectious Diseases (NIAID). The contract is for the delivery of Chromium Next GEM Reagents, which are specialized kits and instruments for single-cell and spatial analysis applications to support biomedical research. The contract opportunity was set aside for small businesses. 10X Genomics is a...

This firm-fixed price purchase order was awarded by the National Institute of Allergy and Infectious Diseases (NIAID), part of the Department of Health and Human Services, to 10X Genomics, Inc. for single-cell and spatial genomics products and services. The $56,935.00 contract provides 10X Genomics' Visium CytAssist instrument, reagent kits, and Visium HD Human Transcriptome products to support NIAID's biomedical research. This procurement was competed as a small business set-aside under NAICS code 334516 for Analytical Laboratory Instrument Manufacturing. 10X Genomics is a life sciences technology company that specializes in genomic analysis platforms and has an existing indefinite delivery contract with NIAID's National Institute of Neurological Disorders and Stroke valued at up to $750,000.

Generated 12/6/24, 9:02 AM